Description
We are looking for a Senior Global Medical Director to provide strategic medical leadership across selected early indication expansion and pipeline opportunities in cardio-renal-metabolic disease.
In this highly visible role, you will ensure Medical Affairs insights are incorporated early and consistently into lifecycle strategy, population segmentation, clinical development, integrated evidence planning, scientific differentiation and launch readiness, connecting R&D, Global Product Strategy, Market Access, Evidence Generation and country Medical teams to build a compelling and medically meaningful value proposition for patients, healthcare professionals, payers and health systems.
Key Responsibilities:
- Lead the global Medical Affairs strategy for assigned indication-expansion opportunities, aligned with overall asset strategy and evolving portfolio priorities.
- Provide senior medical input to indication sequencing, target-population definition, patient segmentation, desired medicine profile, differentiation and the scientific value proposition.
- Partner with Clinical Development on study design, endpoints, data interpretation and the medical relevance of development choices, bringing the external clinical environment and patient pathway into decision-making.
- Lead or co-lead integrated evidence planning for assigned indications, identifying and prioritising evidence gaps across clinical outcomes, PROs, RWE, health outcomes, epidemiology, diagnostics, care pathways and implementation science.
- Drive integrated global scientific communications to support robust evidence narratives and core claims.
Leadership Capabilities:
- Strategic enterprise thinking: connecting disease-area science, asset strategy, evidence, access and healthcare delivery.
- Strong scientific judgment: challenging constructively, distinguishing critical evidence from noise and making clear recommendations under uncertainty.
- External orientation: bringing patient, practitioner, payer and health-system perspectives into strategy and understanding the evolving treatment landscape.
- Collaborative leadership: building trust across functions, geographies and cultures and creating alignment around shared outcomes.
- Execution focus: prioritising ruthlessly, converting strategy into high-quality deliverables and maintaining momentum across multiple workstreams.
- Learning agility: rapidly developing expertise and adapting support as indications and early assets progress.
Basic Criteria for Success:
- MD/MBBS, PharmD or PhD in a clinical or scientific discipline.
- Experience in cardio-renal-metabolic disease, with direct clinical or scientific work in this area.
- Experience in Medical Affairs at global and/or major-market level, with strategic responsibility for an asset or disease area.
- Experience in supporting all stages of clinical development, integrated evidence planning and lifecycle strategy.
- Experience in translating external medical insights and complex evidence into asset strategy, development decisions and executable medical plans.
- Experience in leading within a global matrix, influencing senior cross-functional stakeholders and driving decisions under ambiguity without direct line authority.
Preferred Qualifications and Experience:
- Experience with pre-launch and launch preparation at both global and local level, including evidence generation, scientific communications and omnichannel medical strategy.
- Experience in patient segmentation, endpoint strategy, real-world evidence, health-outcomes research or implementation science.
- Experience contributing to regulatory briefing documents, payer dossiers, guideline-shaping evidence or fulfilling post-approval commitments.
- Experience evaluating early assets or business-development opportunities and informing portfolio decisions in cardio-renal-metabolic disease.
- Robust understanding of diverse healthcare systems, internal and external codes of practice, safety and regulatory requirements, and applicable industry standards.